East WestFreight (540006)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹6.32 |
| Market Cap | ₹81.05 Cr |
| P/E Ratio | 0 |
| ROCE | 6.98% |
| ROE | -7.2% |
| Dividend Yield | 0% |
| Profit Growth | -1,028% |
| Debt/Equity | — |
| Sales Growth | -34.2% |
| 52-Week Range | ₹1.85 — ₹6.32 |
| Sector | Transport Services |
| Book Value | ₹5.43 |
Strengths
- Trading at only 1.16 times book value, with book value of ₹5.43 per share
- Positive ROCE of 6.98% indicates some underlying capital productivity despite the net loss
- Latest quarter sales of ₹41 crore show the business still has meaningful operational scale
- Price has recovered sharply from ₹1.85 to ₹6.32, suggesting possible market expectations of a turnaround
Concerns
- Latest quarter net loss of ₹2 crore and profit growth of -1028% show severe deterioration
- Revenue is shrinking sharply, with sales growth down 34.2%
- Return on equity is deeply negative at -7.20%, destroying shareholder value
- Piotroski F-Score of 3/9 reflects weak financial health, and no dividend is being paid
AI Analysis
Looking at East WestFreight, I first ask if I understand the business. Logistics is a utility-like, high-volume, low-margin industry, and that is not a fertile ground for pricing power. The latest quarter tells me the story: sales of ₹41 crore, yet a net loss of ₹2 crore. Full-year trends are worse—sales down 34.2% and profit growth down 1028%, meaning they have swung into losses. Return on equity is -7.20%, so for every rupee of book value, they are destroying value. The book value is ₹5.43, and the stock is trading at ₹6.32, at 1.16 times book. That is not cheap when earnings are negative; it offers no margin of safety. The positive ROCE of 6.98% is peculiar, but it does not overcome the net loss. The Piotroski F-score of 3 out of 9 tells me the company's financial health is poor. There is no dividend, so shareholders are not being paid to wait. The 52-week range of ₹1.85 to ₹6.32 shows the market has bid this stock up strongly, but I cannot rely on price momentum to protect me. In Benjamin Graham's terms, price is what you pay, value is what you get; right now I don't see clear evidence of value. This may be a turnaround candidate, but I prefer to let the balance sheet and earnings heal before committing capital. I would need several quarters of improving sales, positive net income, and rising ROE.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer